LATEST

HOW IT DEVELOPED

1. Eli Lilly (LLY) Is Suing Six Companies Over an Unapproved Drug—Leaving Novo Nordisk (NVO) Clear in the GLP-1 Wars finance.yahoo.com  ·  24.08 21:04
2. Is the Weight-Loss Drug Market Really a Winner-Take-All Fight Between Novo Nordisk (NVO) and Eli Lilly (LLY)? finance.yahoo.com  ·  24.08 20:29
3. Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can finance.yahoo.com  ·  24.08 00:20
4. Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The Clear Winner investors.com  ·  21.08 14:00